Clinical Trials
2 trialsNCT01430390 2025-06-11
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT06777264 2025-01-15
JUVENTAS-ALL05
First Affiliated Hospital of Zhejiang University
Phase 2 Not yet recruiting